Author: KESHO

Global cancer control: choosing the road less travelled - ⁦Article by our chair Dr. Miriam Mutebi on The Lancet Oncology Journal  Download [...]

Screening and Early Detection for LMICs: Innovations and strategies

CML Registry in Kenya As part of our core objectives KESHO seeks to promote research and increase availability of locally generated data.  We [...]

KESHO GUIDANCE ON COVID VACCINE FOR CANCER PATIENTS Introduction Cancer patients tend to have more co-morbidities, and poorer performance status and are [...]

Cancer patients have been reported to be at higher risk of COVID-19 complications and deaths. We report the characteristics and outcome of patients diagnosed with COVID-19 during breast cancer treatment at Institut Curie hospitals (ICH, Paris area, France)

Early published reports from China indicate that patients living with cancer are at a higher risk of being infected with COVID-19 and having complications from COVID-19 if infected as compared to patients without cancer.